In this Q&A, Latent Labs CEO and AlphaFold co-developer Simon Kohl explains how generative A.I. is transforming biology from a science of prediction to one of design, why programmable drug ...

We’ve been talking about this for years now. Personalized medicine. Or precision medicine, if you prefer that term. The idea is simple enough on paper-stop treating patients like averages and start ...

For millions, attention-deficit/hyperactivity disorder (ADHD) is more than an occasional distraction – it’s a persistent neurodevelopmental condition that can ...

MIT researchers have dramatically lowered the error rate of prime editing, a technique with promise for treating numerous ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

Some conservation groups are calling for an effective ban on genetic modification, but others say these technologies are ...

Long interspersed nuclear element-1 (LINE-1 or L1) is the only active, self-copying genetic element in the human ...

Scientists at the University of Maryland have uncovered the genetic key behind a rare wheat variety that produces three ...

Researchers discovered the gene that gives a rare wheat variety its unusual “triple-grain” trait. When switched on, the gene ...

The gene therapy company uniQure has announced top-level data from its trial of AMT-130, a new gene therapy designed to treat Huntington’s disease. Globally, an estimated 4.88 per 100,000 people ...

Cell and gene therapies (CGTs) are moving rapidly from specialist trials to routine care: more than thirty products are ...